The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by ...

South Africa's Minister of Agriculture announces the country's first-ever vaccination campaign against avian influenza, following the issuance of a permit to Astral Foods. This proactive measure aims ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the ...

A rare cell in the lining of lungs is fundamental to the organ-wide response necessary to repair damage from toxins like ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Purdue University researchers now have developed an innovative, paper-based diagnostic test for rapidly detecting avian ...

During the 2015 outbreak of highly pathogenic avian influenza virus (HPAI) on poultry farms in the midwestern United States, concern was raised about the potential for HPAI to contaminate groundwater.